Results 231 to 240 of about 79,283 (266)

U0126 Protects Cells against Oxidative Stress Independent of Its Function as a MEK Inhibitor

ACS Chemical Neuroscience, 2015
Kai Zhang, Bianxiao Cui, Qunxiang Ong
exaly  

Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma

Cancers, 2019
Richard Carvajal, Omid Hamid, Mark Faries   +2 more
exaly  

The crossregulation between ERK and PI3K signaling pathways determines the tumoricidal efficacy of MEK inhibitor

Journal of Molecular Cell Biology, 2012
Won Do Heo, Hee Won Yang, Sungyoung Shin   +2 more
exaly  

Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutation

Gynecologic Oncology Reports, 2014
Michael Frumovitz, , Yasmin A Lyons
exaly  

KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS

Cell, 2018
Marzia Capelletti, Haiyun Wang, Sudershan Gondi   +2 more
exaly  

MEK MUTATIONS CONFERRING RESISTANCE TO MEK INHIBITORS

2010
GARRAWAY LEVI, EMERY CAROLINE, GARCIA-ECHEVERRIA CARLOS   +2 more
openaire   +5 more sources

COMBINATION OF RAF INHIBITOR AND MEK INHIBITOR

2022
BLACKMAN SAMUEL C, VENETSANAKOS ELENI
openaire   +2 more sources

Transient MEK inhibitor-associated retinopathy in metastatic melanoma

Annals of Oncology, 2014
Reinhard Dummer, Simone M Goldinger, Martin Urner   +2 more
exaly  

Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma

Cancer Chemotherapy and Pharmacology, 2014
Anthony Tolcher, Ferron-Brady Geraldine, Patnaik Amita   +2 more
exaly  

Treatment of asthma with MEK inhibitors

2000
BRIDGES ALEXANDER JAMES, DUDLEY DAVID THOMAS, MOBLEY JAMES LESLIE, SALTIEL ALAN ROBERT   +3 more
openaire   +3 more sources